Novo Integrated Sciences, Inc. engages in the provision of medical services. The company is headquartered in Bellevue, Washington and currently employs 115 full-time employees. The company went IPO on 2005-07-12. The company operates through two reportable segments: healthcare services and product sales. Its businesses include healthcare, medical technology, manufacturing, research and diagnostics, and products and brands. Its specialized primary health care services include physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, and others. Its products include Terragenx and ProDip (dietary supplement pouches). Terragenx is a micro-dosing IoNovo Iodine product for all ages and lifestyles. Its medical technologies include telemedicine, and remote patient monitoring.
Follow-Up Questions
Novo Integrated Sciences Inc 的 CEO 是誰？
Mr. Robert Mattacchione 是 Novo Integrated Sciences Inc 的 Chairman of the Board，自 2018 加入公司。
NVOS 股票的價格表現如何？
NVOS 的當前價格為 $0.0005，在上個交易日 decreased 了 0%。
Novo Integrated Sciences Inc 的主要業務主題或行業是什麼？
Novo Integrated Sciences Inc 屬於 Health Care 行業，該板塊是 Health Care
